Načítá se...
Metformin monotherapy for adults with type 2 diabetes mellitus
BACKGROUND: Worldwide, there is an increasing incidence of type 2 diabetes mellitus (T2DM). Metformin is still the recommended first‐line glucose‐lowering drug for people with T2DM. Despite this, the effects of metformin on patient‐important outcomes are still not clarified. OBJECTIVES: To assess th...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386876/ https://ncbi.nlm.nih.gov/pubmed/32501595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012906.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|